- Info
- Significant Ownership
- Insider Trading
- Financials
- Holders
Significant Ownership of INCYTE CORP
- Signature - Title
- /s/ Sheila A. Denton - Sheila A. Denton / Executive Vice President and General Counsel
- Location
- Wilmington, DE
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by INCYTE CORP.
Follow Filing Activity
Follow INCYTE CORP and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of INCYTE CORP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $6,295,859 | 4,372,124 | INCYTE CORP | 03 Nov 2025 |
Schedules 13D/G Reported by INCYTE CORP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.